Evaluation of API An-IDENT and RapID ANA II systems for identification of Actinomyces species from clinical specimens.
AUTOR(ES)
Miller, P H
RESUMO
We compared the accuracy of the An-IDENT system (bioMerieux Vitek, Inc., Hazelwood, Mo.) and the RapID ANA II system (Innovative Diagnostic Systems, Norcross, Ga.) with that of conventional biochemical tests for the identification of 85 strains of Actinomyces species. In our hands, the overall accuracy of the An-IDENT was 59% and that of the RapID ANA II was 24%. The error rate for the An-IDENT was 18% and that for the RapID ANA II was 38%. The results of this study suggest that although the An-IDENT was more accurate than the RapID ANA II (P < 0.005), neither system, in our hands, was able to identify Actinomyces species with an acceptable degree of accuracy. It is recommended that suspected Actinomyces isolates be identified by conventional testing.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=227942Documentos Relacionados
- Evaluation of the RapID ANA II and API ZYM systems for identification of Actinomyces species from clinical specimens.
- Comparison of API ZYM system with API AN-Ident, API 20A, Minitek Anaerobe II, and RapID-ANA systems for identification of Clostridium difficile.
- Comparison of the PRAS II, AN-Ident, and RapID-ANA systems for identification of anaerobic bacteria.
- API ZYM and API An-Ident reactions of fastidious oral gram-negative species.
- Comparison of PRAS II, RapID ANA, and API 20A systems for identification of anaerobic bacteria.